NDC 72384-753

Stendra

Avanafil

Stendra is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Metuchen Pharmaceuticals, Llc. The primary component is Avanafil.

Product ID72384-753_02c03667-4518-4b43-ae10-f915132a0224
NDC72384-753
Product TypeHuman Prescription Drug
Proprietary NameStendra
Generic NameAvanafil
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2013-12-27
Marketing CategoryNDA / NDA
Application NumberNDA202276
Labeler NameMetuchen Pharmaceuticals, LLC
Substance NameAVANAFIL
Active Ingredient Strength200 mg/1
Pharm ClassesPhosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 72384-753-30

30 TABLET in 1 BOTTLE (72384-753-30)
Marketing Start Date2013-12-27
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Stendra" or generic name "Avanafil"

NDCBrand NameGeneric Name
62541-501STENDRAAvanafil
62541-502STENDRAAvanafil
62541-503STENDRAAvanafil
72384-751Stendraavanafil
72384-752Stendraavanafil
72384-753Stendraavanafil
76299-320Stendraavanafil
76299-321Stendraavanafil
76299-322Stendraavanafil

Trademark Results [Stendra]

Mark Image

Registration | Serial
Company
Trademark
Application Date
STENDRA
STENDRA
85565411 4526269 Live/Registered
METUCHEN PHARMACEUTICALS, LLC
2012-03-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.